Clinical Trials Browser

Phase 4 × Bevacizumab × Other solid neoplasm × Clear all

NCT05525767 2025-12-11

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Phase 4 Recruiting

Other solid neoplasm

Solid Tumor